Drug intelligence / Profile preview

Anti-cold Prescription

Development stage: Preclinical
Lead developer: China Academy of Chinese Medical Sciences
Modality: Small Molecules
Administration: Oral

Overview

Anti-cold Prescription (抗感冒处方) is an experimental Traditional Chinese Medicine (TCM) decoction developed by the China Academy of Chinese Medical Sciences for the treatment of the common cold, specifically the Wind-Heat (Fengre) syndrome. As a TCM formulation, it typically comprises a mixture of various medicinal herbs intended to clear heat, detoxify, and relieve exterior symptoms. It has been evaluated in clinical trials in China to determine its efficacy and safety compared to placebo decoctions in reducing the duration and severity of symptoms associated with viral upper respiratory tract infections.

Other names: Anti-cold Prescription decoction抗感冒处方汤剂Kang Gan Mao Chu Fang

Beyond the preview

Go deeper on Anti-cold Prescription.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anti-cold Prescription.

Explore the full profile